Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114679) titled 'Molecular Breast Imaging (MBI)-Guided Biopsy' on Aug. 3.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Screening. Masking: None (Open Label).
Primary Sponsor: Smart Breast Corp.
Condition:
Breast Cancer Detection
Breast Neoplasm
Molecular Imaging
Biopsy
Dense Breasts
Intervention:
Device: Molecular Breast Imaging
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 2027
Target Sample Size: 250
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07114679
Publ...